Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

Delayed Quote. Delayed  - 09/27 10:02:09 pm
42.33 USD   +1.56%
09/21 ABBOTT LABORATO : Malnutrition Adds $15.5 Billion Annually to Direct..
09/21DJABBOTT LABORATO : to Delist from London Stock Exchange
09/21 ABBOTT : Hosts Conference Call for Third-Quarter Earnings
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales21 84820 24720 40520 93922 05023 297
Operating income (EBITDA)4 9745 8624 8505 0495 4475 870
Operating profit (EBIT)4 0464 3143 9793 9254 4004 694
Pre-Tax Profit (EBT)2 521-----
Net income2 5762 2844 4232 2353 3323 614
P/E ratio23,730,215,423,718,316,4
EPS ( $ )1,621,492,921,792,312,58
Dividend per Share ( $ )0,640,900,981,041,141,24
Yield1,67%2,00%2,18%2,45%2,69%2,92%
Reference price ( $ )38.3345.0244.9142.3342.3342.33
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt3 0863 7822 8762 6993 1922 990
Finance------
Operating income (EBITDA)4 9745 8624 8505 0495 4475 870
Leverage
(Debt/EBITDA)
0,62x0,65x0,59x0,53x0,59x0,51x
Capital Expenditure1 1451 0771 1101 1841 1551 256
Book Value Per Share (BVPS)16,3 $14,3 $14,4 $15,3 $16,6 $17,9 $
Cash Flow per Share2,11 $2,41 $1,97 $2,46 $3,34 $3,45 $
Announcement Date01/22/2014
12:44pm
01/29/2015
12:45pm
01/28/2016
12:31pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 62 225 M$ -
Entreprise Value (EV) 64 924 M$ 65 417 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 23,7x 18,3x
Capitalization / Revenue 2,97x 2,82x
EV / Revenue 3,10x 2,97x
EV / EBITDA 12,9x 12,0x
Yield (DPS / Price) 2,45% 2,69%
Price to book (Price / BVPS) 2,76x 2,55x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 18,7% 20,0%
operating Leverage (Delta EBIT / Delta Sales) - 2,28x
Net Margin (Net Profit / Revenue) 10,7% 15,1%
ROA (Net Profit / Asset) 7,38% 8,85%
ROE (Net Profit / Equities) 14,5% 16,0%
Rate of Dividend 58,1% 49,3%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   5,65% 5,24%
Cash Flow / Sales 17,3% 22,3%
Capital Intensity (Assets / Sales) 1,45x 1,71x
Financial Leverage (Net Debt / EBITDA) 0,53x 0,59x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend